Literature DB >> 18729719

Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.

Casandra M Cartagena1, Farid Ahmed, Mark P Burns, Ahdeah Pajoohesh-Ganji, Daniel T Pak, Alan I Faden, G William Rebeck.   

Abstract

In traumatic brain injury (TBI), cellular loss from initial impact as well as secondary neurodegeneration leads to increased cholesterol and lipid debris at the site of injury. Cholesterol accumulation in the periphery can trigger inflammatory mechanisms while cholesterol clearance may be anti-inflammatory. Here we investigated whether TBI altered the regulation of cholesterol 24S-hydroxylase (Cyp46), an enzyme that converts cholesterol to the more hydrophilic 24S-hydroxycholesterol. We examined by Western blot and immunohistochemistry changes in Cyp46 expression following fluid percussion injury. Under normal conditions, most Cyp46 was present in neurons, with very little measurable in glia. Cyp46 levels were significantly increased at 7 days post-injury, and cell type specific analysis at 3 days post-injury showed a significant increase in levels of Cyp46 (84%) in microglia. Since 24-hydroxycholesterol induces activation of genes through the liver X receptor (LXR), we examined protein levels of ATP-binding cassette transporter A1 and apolipoprotein E, two LXR regulated cholesterol homeostasis proteins. Apolipoprotein E and ATP-binding cassette transporter A1 were increased at 7 days post-injury, indicating that increased LXR activity coincided with increased Cyp46 levels. We found that activation of primary rat microglia by LPS in vitro caused increased Cyp46 levels. These data suggest that increased microglial Cyp46 activity is part of a system for removal of damaged cell membranes post-injury, by conversion of cholesterol to 24-hydroxycholesterol and by activation of LXR-regulated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729719      PMCID: PMC2745316          DOI: 10.1089/neu.2007.0444

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  60 in total

1.  Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.

Authors:  Ashley D Reynolds; Jason G Glanzer; Irena Kadiu; Mary Ricardo-Dukelow; Anathbandhu Chaudhuri; Pawel Ciborowski; Ronald Cerny; Benjamin Gelman; Mark P Thomas; R Lee Mosley; Howard E Gendelman
Journal:  J Neurochem       Date:  2007-11-22       Impact factor: 5.372

2.  Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep.

Authors:  S D Turley; D K Burns; C R Rosenfeld; J M Dietschy
Journal:  J Lipid Res       Date:  1996-09       Impact factor: 5.922

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias.

Authors:  B L Plassman; R J Havlik; D C Steffens; M J Helms; T N Newman; D Drosdick; C Phillips; B A Gau; K A Welsh-Bohmer; J R Burke; J M Guralnik; J C Breitner
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

5.  Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury.

Authors:  Z Zhang; U Fauser; H J Schluesener
Journal:  Neuropathol Appl Neurobiol       Date:  2007-11-05       Impact factor: 8.090

Review 6.  Glial reactions in Parkinson's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

Review 7.  High-density lipoprotein: antioxidant and anti-inflammatory properties.

Authors:  Mohamad Navab; Roger Yu; Nima Gharavi; William Huang; Navid Ezra; Ali Lotfizadeh; G M Anantharamaiah; Nima Alipour; Brian J Van Lenten; Srinivasa T Reddy; Daniel Marelli
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

8.  Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.

Authors:  Pazit Bar-On; Leslie Crews; Andrew O Koob; Hideya Mizuno; Anthony Adame; Brian Spencer; Eliezer Masliah
Journal:  J Neurochem       Date:  2008-01-28       Impact factor: 5.372

9.  Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain.

Authors:  Denise M O Ramirez; Stefan Andersson; David W Russell
Journal:  J Comp Neurol       Date:  2008-04-10       Impact factor: 3.215

10.  LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.

Authors:  Daniel Walcher; Andreas Kümmel; Bettina Kehrle; Helga Bach; Miriam Grüb; Renate Durst; Vinzenz Hombach; Nikolaus Marx
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-16       Impact factor: 8.311

View more
  20 in total

1.  Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury.

Authors:  Emilie L Castranio; Anais Mounier; Cody M Wolfe; Kyong Nyon Nam; Nicholas F Fitz; Florent Letronne; Jonathan Schug; Radosveta Koldamova; Iliya Lefterov
Journal:  Neurobiol Dis       Date:  2017-05-11       Impact factor: 5.996

Review 2.  Changes in brain cholesterol metabolome after excitotoxicity.

Authors:  Wei-Yi Ong; Ji-Hyun Kim; Xin He; Peng Chen; Akhlaq A Farooqui; Andrew M Jenner
Journal:  Mol Neurobiol       Date:  2010-02-06       Impact factor: 5.590

3.  Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner.

Authors:  Kosara Smiljanic; Irena Lavrnja; Aleksandra Mladenovic Djordjevic; Sabera Ruzdijic; Mirjana Stojiljkovic; Sanja Pekovic; Selma Kanazir
Journal:  Histochem Cell Biol       Date:  2010-06-18       Impact factor: 4.304

Review 4.  Cholesterol metabolism in Huntington disease.

Authors:  Joanna M Karasinska; Michael R Hayden
Journal:  Nat Rev Neurol       Date:  2011-09-06       Impact factor: 42.937

5.  24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Authors:  Casandra M Cartagena; Mark P Burns; G William Rebeck
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

6.  Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3.

Authors:  Casandra M Cartagena; Katie L Phillips; Garry L Williams; Melissa Konopko; Frank C Tortella; Jitendra R Dave; Kara E Schmid
Journal:  Neuromolecular Med       Date:  2013-06-14       Impact factor: 3.843

7.  Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.

Authors:  Aicha Saadane; Natalia Mast; George Trichonas; Dibyendu Chakraborty; Sandra Hammer; Julia V Busik; Maria B Grant; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2018-11-16       Impact factor: 4.307

8.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

9.  Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury.

Authors:  Jennifer N Dulin; Edward D Karoly; Ying Wang; Henry W Strobel; Raymond J Grill
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

Review 10.  Cholesterol in brain disease: sometimes determinant and frequently implicated.

Authors:  Mauricio G Martín; Frank Pfrieger; Carlos G Dotti
Journal:  EMBO Rep       Date:  2014-09-15       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.